A shadow market for unlicensed slimming drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, according to recent findings.
Experimental Drug Gaining Traction Online
Retatrutide, which is still in research studies, is being promoted by social media influencers for its supposed weight-reducing effects. Followers are encouraged to message these accounts directly for supplier links, while also receiving discount codes.
Active Commerce on Social Networks
Additionally, a robust market exists on Telegram, where communities with thousands of members share “before and after” images, administration instructions and claims of rapid British shipping. Vendors promote the substance there before redirecting customers to WhatsApp for transactions.
Learning About Retatrutide
This medication is an investigational injectable developed by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could help patients reduce up to 25% of their total weight. Nicknamed the “triple G”, the substance is being promoted digitally as the next Ozempic.
Medical Professionals Express Concerns
Nevertheless, doctors and pharmacists have warned that the distribution of what remains an unapproved medication in the UK is a cause for concern and could result in users injecting substances of unknown origin.
Several experts said the popularity for retatrutide could be linked to the increasing price of licensed slimming products such as Mounjaro.
Legal Status and Enforcement
Selling retatrutide on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unapproved drug that must not be marketed or supplied for personal consumption under the British medical regulations.
Some influencers try to sidestep the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and distribution can still breach medicines, marketing, and customer regulations, risking penalties, prosecution or imprisonment.
Platform Reaction and Material Elimination
Based on the social media company, the service has removed problematic content and prohibited associated hashtags and query recommendations. The organization said it was dedicated to keeping the platform secure and investing in strengthening enforcement strategies.
Online Trading Activities
Investigations also found communities with up to 9,000 participants marketing the experimental drug using the platform's built-in discovery tool, which functions like a online catalog. Typing “retatrutide” instantly brings up channels with numerous of members, filled with photos of slimming results, positive reviews and detailed instructions for preparing or administering at home.
After minutes of joining one community, a seller posted contact information, where most transactions occur. The seller provided an instruction manual and promised delivery within 48 hours. When questioned whether the substance was authentic, one vendor said: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. Not one inquired about body mass, medical conditions or past usage.
Item Information and Pricing
Within these communities, posts display dark colored parcels with postal service stickers, stating to include fresh supplies. One message stated: “It took eight of us to load them this morning.”
Buyers can choose between dry substance containers, prepared at residence with purified liquid, or pre-filled injectors typically sold at 160 pounds for 20mg. When questioned how long a injector should last, vendors give conflicting answers varying between a few weeks to “depends on your body”.
Platform Oversight and Security Actions
A representative for Telegram stated it regularly monitored dangerous material on its platform including content that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“Individuals are administering substances they cannot confirm. Although the science behind this drug is valid, these digital products may not contain what they claim,” said a pharmacy expert, the director of pharmaceutical services at Chemist4U.
Dr Crystal Wyllie of Asda Online Doctor linked the surge in interest to recent cost increases for approved weight-loss drugs such as Mounjaro. “With prices rising, patients are using online platforms. But counterfeit treatments are highly dangerous. You cannot know what’s contained or whether the environment they were made in was clean,” she explained.
Her team has already seen patients injured by self-injection from unconfirmed sources. “We recognize the disappointment, but buying from messaging apps or WhatsApp is taking chances with your well-being,” said Wyllie. “These materials could be contaminated or incorrectly dosed.”
Manufacturer Statement
A representative from Eli Lilly stated the substance was in third stage research studies and had not been evaluated or approved by any government authority globally. “Therefore at this time no one can sell [it] for human use,” they explained, adding that any product “misleadingly claiming itself as a Lilly experimental product not yet authorized … may subject users to potentially significant health risks”.
